Relationship between institutional ventilated COVID-19 case volume and in-hospital death: A multicenter cohort study.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 05 05 2022
accepted: 03 06 2023
medline: 19 6 2023
pubmed: 15 6 2023
entrez: 15 6 2023
Statut: epublish

Résumé

The volume-outcome relationship in patients with severe Coronavirus disease 2019 (COVID-19) is unclear and is important for establishing a system for the medical care of severe COVID-19. This study aimed to evaluate the association between institutional case volume and outcomes in patients with ventilated COVID-19. We analyzed patients with severe COVID-19 on ventilatory control aged > 17 years who were enrolled in the J-RECOVER study, which is a retrospective multicenter observational study conducted between January 2020 and September 2020 in Japan. Based on the ventilated COVID-19 case volume, the higher one-third of institutions were defined as high-volume centers, the middle one-third as middle-volume centers, and the lower one-third as low-volume centers. The primary outcome measure was in-hospital mortality during hospitalization due to COVID-19. Multivariate logistic regression analysis for in-hospital mortality and ventilated COVID-19 case volume was performed after adjusting for multiple propensity scores and in-hospital variables. To estimate the multiple propensity score, we fitted a multinomial logistic regression model, which fell into one of the three groups based on patient demographics and prehospital factors. We analyzed 561 patients who required ventilator management. In total, 159, 210, and 192 patients were admitted to low-volume (36 institutions, < 11 severe COVID-19 cases per institution during the study period), middle-volume (14 institutions, 11-25 severe cases per institution), and high-volume (5 institutions, > 25 severe cases per institution) centers, respectively. After adjustment for multiple propensity scores and in-hospital variables, admission to middle- and high-volume centers was not significantly associated with in-hospital death compared with admission to low-volume centers (adjusted odds ratio, 0.77 [95% confidence interval (CI): 0.46-1.29] and adjusted odds ratio, 0.76 [95% CI: 0.44-1.33], respectively). There may be no significant relationship between institutional case volume and in-hospital mortality in patients with ventilated COVID-19.

Sections du résumé

BACKGROUND
The volume-outcome relationship in patients with severe Coronavirus disease 2019 (COVID-19) is unclear and is important for establishing a system for the medical care of severe COVID-19. This study aimed to evaluate the association between institutional case volume and outcomes in patients with ventilated COVID-19.
METHODS
We analyzed patients with severe COVID-19 on ventilatory control aged > 17 years who were enrolled in the J-RECOVER study, which is a retrospective multicenter observational study conducted between January 2020 and September 2020 in Japan. Based on the ventilated COVID-19 case volume, the higher one-third of institutions were defined as high-volume centers, the middle one-third as middle-volume centers, and the lower one-third as low-volume centers. The primary outcome measure was in-hospital mortality during hospitalization due to COVID-19. Multivariate logistic regression analysis for in-hospital mortality and ventilated COVID-19 case volume was performed after adjusting for multiple propensity scores and in-hospital variables. To estimate the multiple propensity score, we fitted a multinomial logistic regression model, which fell into one of the three groups based on patient demographics and prehospital factors.
RESULTS
We analyzed 561 patients who required ventilator management. In total, 159, 210, and 192 patients were admitted to low-volume (36 institutions, < 11 severe COVID-19 cases per institution during the study period), middle-volume (14 institutions, 11-25 severe cases per institution), and high-volume (5 institutions, > 25 severe cases per institution) centers, respectively. After adjustment for multiple propensity scores and in-hospital variables, admission to middle- and high-volume centers was not significantly associated with in-hospital death compared with admission to low-volume centers (adjusted odds ratio, 0.77 [95% confidence interval (CI): 0.46-1.29] and adjusted odds ratio, 0.76 [95% CI: 0.44-1.33], respectively).
CONCLUSIONS
There may be no significant relationship between institutional case volume and in-hospital mortality in patients with ventilated COVID-19.

Identifiants

pubmed: 37319278
doi: 10.1371/journal.pone.0287310
pii: PONE-D-22-13235
pmc: PMC10270613
doi:

Types de publication

Multicenter Study Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0287310

Informations de copyright

Copyright: © 2023 Amagasa et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Health Serv Res. 2009 Jun;44(3):862-79
pubmed: 19674428
Med Care. 2010 Feb;48(2):166-74
pubmed: 20068488
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Ann Intern Med. 2002 Sep 17;137(6):511-20
pubmed: 12230353
Intensive Care Med. 2004 Feb;30(2):290-297
pubmed: 14685662
N Engl J Med. 2006 Jul 6;355(1):41-50
pubmed: 16822995
Lancet. 2020 Jun 6;395(10239):1763-1770
pubmed: 32442528
Chest. 2015 Jul;148(1):79-92
pubmed: 25927593
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
Crit Care Med. 2012 Sep;40(9):2569-75
pubmed: 22732289
CMAJ. 2020 Jun 29;192(26):E694-E701
pubmed: 32461326
Resuscitation. 2019 Apr;137:161-167
pubmed: 30802557
Crit Care Med. 2016 Mar;44(3):488-95
pubmed: 26496447
JAMA Intern Med. 2020 Oct 1;180(10):1345-1355
pubmed: 32667669
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Am J Respir Crit Care Med. 2021 Jan 1;203(1):54-66
pubmed: 33119402
Crit Care Med. 2006 Sep;34(9):2349-54
pubmed: 16878036
Crit Care Med. 2015 Jun;43(6):1239-45
pubmed: 25756414
Anesthesiology. 2013 Oct;119(4):871-9
pubmed: 23838712
Crit Care Med. 2019 Mar;47(3):360-368
pubmed: 30585831
J Intensive Care. 2020 Jun 15;8:40
pubmed: 32549989
BMJ. 2009 Jun 29;338:b2393
pubmed: 19564179
Med Care. 2005 Nov;43(11):1130-9
pubmed: 16224307
Intensive Care Med. 2015 Feb;41(2):304-11
pubmed: 25600188
Stat Med. 2012 Mar 30;31(7):681-97
pubmed: 21351291
Intensive Care Med. 1996 Jul;22(7):707-10
pubmed: 8844239
Crit Care Med. 2018 May;46(5):764-773
pubmed: 29394181

Auteurs

Shunsuke Amagasa (S)

Division of Emergency and Transport Services, National center for Child Health and Development, Okura, Setagaya-ku, Tokyo, Japan.

Satoko Uematsu (S)

Department of Interdisciplinary Medicine, Division of General Pediatrics, National Center for Child Health and Development, Okura, Setagaya-ku, Tokyo, Japan.

Mitsuru Kubota (M)

Department of Interdisciplinary Medicine, Division of General Pediatrics, National Center for Child Health and Development, Okura, Setagaya-ku, Tokyo, Japan.

Masahiro Kashiura (M)

Department of Emergency and Critical Care Medicine, Saitama Medical Center, Jichi Medical University, Amanuma-cho, Omiya-ku, Saitama City, Saitama, Japan.

Hideto Yasuda (H)

Department of Emergency and Critical Care Medicine, Saitama Medical Center, Jichi Medical University, Amanuma-cho, Omiya-ku, Saitama City, Saitama, Japan.

Mineji Hayakawa (M)

Department of Emergency Medicine, Hokkaido University Hospital, Kita-ku, Sapporo, Japan.

Kazuma Yamakawa (K)

Department of Emergency Medicine, Osaka Medical and Pharmaceutical University, Daigakumachi, Takatsuki, Osaka, Japan.

Akira Endo (A)

Trauma and Acute Critical Care Center, Tokyo Medical and Dental University Hospital, Yushima, Bunkyo-ku, Tokyo, Japan.

Takayuki Ogura (T)

Department of Emergency Medicine and Critical Care Medicine, Tochigi Prefectural Emergency and Critical Care Centre, Imperial Foundation Saiseikai Utsunomiya Hospital, Takebayashi-machi, Utsunomiya, Tochigi, Japan.

Atsushi Hirayama (A)

Department of Social Medicine, Public Health, Graduate School of Medicine, Osaka University, Yamadaoka, Suita, Japan.

Hideo Yasunaga (H)

Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Hongo, Bunkyo-ku, Tokyo, Japan.

Takashi Tagami (T)

Department of Emergency and Critical Care Medicine, Nippon Medical School Musashikosugi Hospital, Kosugimachi, Nakahara-ku, Kawasaki, Kanagawa, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH